Position in GILD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$831,760
+$593,654 QoQ
Shares Held
5,968
+180.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Perbak Capital Partners LLP holds $831,760 across 1 Drug Manufacturers - General name. GILD ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
This page
|
5,968 | $831,760 |
All Filings in GILD
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $831,760 | 5,968 | Shares | Sole | 2026-05-15 | |
| 2025-03-31 | $238,106 | 2,125 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||